LA
LUKE ALBERT
ARNOLD & PORTER KAYE SCHOLER LLP · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
6
last 3 years
Filings
16
8 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Intern
Rep. Kendra Horn
2019
Disclosed on LD-2 filings
Career
AP
Specific issues
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Issues related to CMS coverage of anti-obesity medications, including the Treat and Reduce Obesity Act of 2023 (H.R. 4818 / S. 2407).
Issues related to pharmacy benefit managers (PBMs) and the 340B Program.
Issues related to pharmacy benefit managers (PBMs) and the 340B program. Issues related to the clinical and overall benefit of anti-obesity medications. Issues related to insulin pricing/affordability.
Issues related to manufacturing capacity and supply chain resiliency.
Issues related to raising awareness for the need to revise the federal poverty measure to reflect cost of living changes.
Clients
Filing history
GENETIX BIOTHERAPEUTICS, INC.
NOVO NORDISK, INC.
NOVO NORDISK A/S
COMMUNITY SERVICE SOCIETY OF NEW YORK
FEDERATION OF PROTESTANT WELFARE AGENCIES
NOVO NORDISK A/S
GENETIX BIOTHERAPEUTICS, INC.
PERRIGO COMPANY PLC
COMMUNITY SERVICE SOCIETY OF NEW YORK
FEDERATION OF PROTESTANT WELFARE AGENCIES
NOVO NORDISK, INC.
PERRIGO COMPANY PLC